Clinical Trials Directory

Trials / Terminated

TerminatedNCT03216863

Home Respiratory Rehabilitation in Advanced Lung Cancer Chemotherapy Per os

Home Respiratory Rehabilitation in Patients With Lung Cancer Non-small Cell Advanced or Metastatic Treated With Oral Targeted Therapy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The feasibility and impact of respiratory rehabilitation (RR) in patients with advanced or metastatic (EGF-R WT or mutated) non-small cell lung cancer treated with oral targeted therapy including Inhibitors of EGF-R tyrosine kinases (TKI) and ALK inhibitors. These patients will benefit, at the beginning of the chemotherapy whatever the treatment line, of a respiratory rehabilitation. The respiratory rehabilitation takes place at the patient's home with the HAD's cooperation 3 hours per week, divided into 2 or 3 sessions. There is associated educational, nutritional and psychological support for a total duration of 8 weeks.

Conditions

Interventions

TypeNameDescription
OTHERRespiratory rehabilitationIt consists of a global care of the patient: therapeutic education, nutritional maintenance, psychological support and re-training to the effort at home after discharge or after follow up visit of targeted therapy

Timeline

Start date
2015-08-03
Primary completion
2017-08-01
Completion
2017-08-01
First posted
2017-07-13
Last updated
2018-05-16

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03216863. Inclusion in this directory is not an endorsement.